SamjinPharm’s ‘Research for Targeted Therapy for Metastatic Breast Cancer’ selected for government’s support
SamjinPharm(CEO Sung-Woo Lee) Central Laboratory announced its ‘Development Project of Targeted Therapy for Metastatic Breast Cancer Patients’ was selected as part of the ‘New Drug Development Pipeline Management Project’ organized by the Ministry of Science, ICT and Future Planning.
The develop...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
